GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$177.80
Tradestie Score
48
Market Cap
$7.81B
Revenue Growth
0.4%
Analyst Upside
+10.8%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IQV
IQVIA Holdings Inc.
|
$258.21
|
$34.64B | 32.3 | 50 | Compare |
|
MTD
Mettler-Toledo International
|
$1486.19
|
$26.57B | 34.0 | 36 | Compare |
|
LH
Labcorp Holdings Inc.
|
$308.49
|
$23.19B | 25.2 | 67 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$410.35
|
$22.18B | - | 36 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$233.33
|
$20.36B | 24.5 | 56 | Compare |
|
WAT
Waters Corp
|
$425.21
|
$19.04B | 111.1 | 53 | Compare |
|
ILMN
Illumina Inc
|
$273.04
|
$15.72B | 49.6 | 37 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$599.47
|
$15.28B | 35.1 | 38 | Compare |
|
ICLR
Icon Plc
|
$162.05
|
$14.96B | 261.0 | 40 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
More GH Analysis
Data updated: Oct 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry